Multiple myeloma Clinical Trials in Denver, CO
As of August 2026, 18 paid clinical trials are recruiting for Multiple myeloma in Denver, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Denver
Filter results
18 clinical trials for Multiple myeloma
·Clear filters·A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
Top Research Study Locations in Denver
Researchers run research studies in Denver, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Colorado Blood Cancer Institute | Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia | 44 |
| National Jewish Health | Cystic Fibrosis, Pulmonary Hypertension, Asthma | 41 |
| Sarah Cannon Research Institute at HealthONE | Advanced Solid Tumor, Solid Tumor, Metastatic Solid Tumor | 26 |
| Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Mixed Phenotype Acute Leukemia | 17 |
| Rocky Mountain Cancer Centers | Breast Cancer, Colorectal Neoplasms, Breast Neoplasms | 16 |
| Kaiser Permanente-Franklin | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 14 |
| UCHealth - Cherry Creek | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | 14 |
| University of Colorado | B Cell Lymphoma, B-Cell Non-Hodgkin's Lymphoma, CADASIL | 13 |
| Denver Health Medical Center | Acute Respiratory Failure, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 12 |
| Children's Hospital Colorado | ALL, AML, Acute Respiratory Distress Syndrome | 10 |
| University of Colorado Denver | Amyotrophic Lateral Sclerosis, Attention, Behavioral Variant Frontotemporal Dementia (bvFTD) | 10 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Urothelial Cancer, Advanced Renal Cell Carcinoma | 9 |
| Denver Health and Hospital Authority | Sepsis, ARDS, Acute Otitis Media | 9 |
| Saint Joseph Hospital - Cancer Centers of Colorado | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 8 |
| Presbyterian - Saint Lukes Medical Center - Health One | Malignant Solid Neoplasm, Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8 | 7 |
| Rocky Mountain Cancer Centers-Midtown | Malignant Solid Neoplasm, Non-Hodgkin Lymphoma, Acral Lentiginous Melanoma | 7 |
| Rocky Mountain Cancer Centers-Rose | Malignant Solid Neoplasm, Non-Hodgkin Lymphoma, Acral Lentiginous Melanoma | 7 |
| AdventHealth Porter | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 6 |
| National Jewish Health-Main Campus | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 6 |
| Sarah Cannon Research Institute | Gastric Cancer, Locally Advanced or Metastatic Solid Tumors, Pancreatic Cancer | 6 |
| The Women's Imaging Center | Malignant Solid Neoplasm, Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8 | 6 |
| Cancer Center of Colorado at Sloan's Lake | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 5 |
| Children's Hospital of Colorado | Adolescent, Bowel Incontinence, CBL Syndrome | 5 |
| Denver Arthritis Clinic - Lowry | Gout, Psoriatic Arthritis, Systemic Lupus Erythematosus | 5 |
| Denver Health | Angina, Stable, Cardiovascular Diseases, Communication Disabilities | 5 |
Active & Upcoming Studies in Denver (2026)
Recruiting trials in Denver grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (222 active studies)
- Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment · University of Colorado, Denver
- A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma · Phase 2 · SCRI Development Innovations, LLC
Cardiovascular (16 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Optimal Ventilation for Cardiac Arrest · Children's Hospital of Philadelphia
Diabetes & metabolic (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes · Insulet Corporation
Mental health & behavior (7 active studies)
- Occupational Therapy for Mental Health and Engagement in Neurorehabilitation · Colorado State University
- Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt · University of Colorado, Denver
Pediatric (7 active studies)
- Meet Me on the Pitch: Developing and Testing a Community-Based Sports and Behavioral Health Intervention for Youth · University of California, San Francisco
- Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections · Intermountain Health Care, Inc.
Neurology & pain (6 active studies)
- CF Wellness Program · Johns Hopkins University
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 · Kyverna Therapeutics
Eye & vision (5 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
HIV / STI (3 active studies)
- Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention · Gilead Sciences
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) · Phase 2, Phase 3 · Merck Sharp & Dohme LLC
Vaccines (2 active studies)
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. · Phase 2 · Vasomune Therapeutics, Inc.
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry · Massive Bio, Inc.
Common conditions studied in Denver
- Multiple Myeloma (18 active studies)
- Breast Cancer (16 active studies)
- Advanced Solid Tumor (15 active studies)
- Endometrial Cancer (11 active studies)
- Ovarian Cancer (11 active studies)
- Solid Tumor (11 active studies)
Leading research sponsors in Denver
- University of Colorado, Denver
- AstraZeneca
- Children's Oncology Group
- National Cancer Institute (NCI)
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Denver?
There are approximately 521 recruiting clinical trials in Denver, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Denver pay participants?
Most recruiting trials in Denver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Denver?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Denver?
The most common conditions under active study in Denver include Multiple Myeloma (18), Breast Cancer (16), Advanced Solid Tumor (15), Endometrial Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Denver?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Denver?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Denver?
Recruiting research sites in Denver include Colorado Blood Cancer Institute, National Jewish Health, Sarah Cannon Research Institute at HealthONE, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Denver right now?
The largest active categories in Denver are Cancer & tumors (222), Cardiovascular (16), Diabetes & metabolic (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.